ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)

ClinicalTrials.gov ID: NCT02790606

Public ClinicalTrials.gov record NCT02790606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Multi-Center Clinical Study of the Bard® COVERA™ Arteriovenous (AV) Stent Graft in the Treatment of Stenosis at the Graft-Vein Anastomosis of AV Graft Circuits (AVeVA)

Study identification

NCT ID
NCT02790606
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
C. R. Bard
Industry
Enrollment
110 participants

Conditions and interventions

Interventions

  • Covera(TM) Vascular Covered Stent Device

Device

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2016
Primary completion
Jul 31, 2017
Completion
Mar 15, 2019
Last update posted
Apr 13, 2020

2016 – 2019

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
15
Facility City State ZIP Site status
Arizona Kidney Disease and Hypertension Center Phoenix Arizona 85012
Southwest Vascular Center Tempe Arizona 85281
Arizona Kidney Disease and Hypertension Center Medical Research Services, LLC Tucson Arizona 85712
St. Joseph Hospital Orange California 92868
Capital Nephrology Access Center Sacramento California 95815
Jacksonville Center for Clinical Research Jacksonville Florida 32207
Ocala Kidney Group Ocala Florida 34471
Chicago Access Care Chicago Illinois 60521
Renal and Transplant Associates of New England, P.C. West Springfield Massachusetts 01089
The Cardiovascular Care Group Westfield New Jersey 07090
Surgical Specialists of Charlotte Charlotte North Carolina 28207
NC Heart and Vascular Research Raleigh North Carolina 27607
NC Nephrology Raleigh North Carolina 27610
Providence Access Care Providence Rhode Island 02906
Tarrant Vascular Clinic Fort Worth Texas 76104
Clinical Advancement Center, PLLC San Antonio Texas 78215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02790606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2020 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02790606 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →